CVS Caremark, a CVS Health company, late Jan. 4 announced that effective April 1, 2024, AbbVie's Humira will be removed from its major national commercial template formularies and Humira biosimilars ...
As part of updates to its standard formulary, CVS Caremark has removed Amjevita and now prefers Hyrimoz and an unbranded biosimilar. Beginning in January 2024, CVS Caremark will implement many changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results